Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

BACKGROUND: Staphylococci represent the first etiologic agents of bone and joint infection (BJI), leading glycopeptides use, especially in case of methicillin-resistance or betalactam intolerance. Teicoplanin may represent an alternative to vancomycin because of its acceptable bone penetration and p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Peeters, Olivier, Ferry, Tristan, Ader, Florence, Boibieux, André, Braun, Evelyne, Bouaziz, Anissa, Karsenty, Judith, Forestier, Emmanuel, Laurent, Frédéric, Lustig, Sébastien, Chidiac, Christian, Valour, Florent
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093939/
https://ncbi.nlm.nih.gov/pubmed/27809799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1955-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados